Scott Maucione
April 13, 2026
Excerpt:
“The Maryland Prescription Drug Affordability Board voted Monday to move forward with setting upper payment limits on the diabetes drug Jardiance, putting into motion the mechanics to put the first state regulations on a drug since the panel’s inception.
With the vote, the limit will now move to a 30-day public comment period before getting a final vote and becoming policy. The limit will impact state and local government health plans starting 2027, effectively setting a ceiling on what the state says it will pay for the drug. The rule will save about $320,000 a year.”
“Vincent DeMarco, president of Maryland Healthcare for All!, says the vote is the culmination of years of work.
“The important thing is that when they see a drug like Jardiance, which is causing affordability issues, they will set an upper payment limit and this is a great step forward for Maryland,” DeMarco said.”
Read the full article on WYPR
Last modified: April 23, 2026
